Strategies for the treatment of breast cancer: from classical drugs to mathematical models

Breast cancer is one of the most common cancers and generally affects women. It is a heterogeneous disease that presents different entities, different biological characteristics, and differentiated clinical behaviors. With this in mind, this literature review had as its main objective to analyze the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ana Costa, Nuno Vale
Formato: article
Lenguaje:EN
Publicado: AIMS Press 2021
Materias:
Acceso en línea:https://doaj.org/article/f221b853853047fda4c15f7bfe26d186
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f221b853853047fda4c15f7bfe26d186
record_format dspace
spelling oai:doaj.org-article:f221b853853047fda4c15f7bfe26d1862021-11-11T01:24:09ZStrategies for the treatment of breast cancer: from classical drugs to mathematical models10.3934/mbe.20213161551-0018https://doaj.org/article/f221b853853047fda4c15f7bfe26d1862021-07-01T00:00:00Zhttps://www.aimspress.com/article/doi/10.3934/mbe.2021316?viewType=HTMLhttps://doaj.org/toc/1551-0018Breast cancer is one of the most common cancers and generally affects women. It is a heterogeneous disease that presents different entities, different biological characteristics, and differentiated clinical behaviors. With this in mind, this literature review had as its main objective to analyze the path taken from the simple use of classical drugs to the application of mathematical models, which through the many ongoing studies, have been considered as one of the reliable strategies, explaining the reasons why chemotherapy is not always successful. Besides, the most commonly mentioned strategies are immunotherapy, which includes techniques and therapies such as the use of antibodies, cytokines, antitumor vaccines, oncolytic and genomic viruses, among others, and nanoparticles, including metallic, magnetic, polymeric, liposome, dendrimer, micelle, and others, as well as drug reuse, which is a process by which new therapeutic indications are found for existing and approved drugs. The most commonly used pharmacological categories are cardiac, antiparasitic, anthelmintic, antiviral, antibiotic, and others. For the efficient development of reused drugs, there must be a process of exchange of purposes, methods, and information already available, and for their better understanding, computational mathematical models are then used, of which the methods of blind search or screening, based on the target, knowledge, signature, pathway or network and the mechanism to which it is directed, stand out. To conclude it should be noted that these different strategies can be applied alone or in combination with each other always to improve breast cancer treatment.Ana CostaNuno ValeAIMS Pressarticlebreast cancerdrug repurposingimmunotherapynanoparticlesmathematical modelsBiotechnologyTP248.13-248.65MathematicsQA1-939ENMathematical Biosciences and Engineering, Vol 18, Iss 5, Pp 6328-6385 (2021)
institution DOAJ
collection DOAJ
language EN
topic breast cancer
drug repurposing
immunotherapy
nanoparticles
mathematical models
Biotechnology
TP248.13-248.65
Mathematics
QA1-939
spellingShingle breast cancer
drug repurposing
immunotherapy
nanoparticles
mathematical models
Biotechnology
TP248.13-248.65
Mathematics
QA1-939
Ana Costa
Nuno Vale
Strategies for the treatment of breast cancer: from classical drugs to mathematical models
description Breast cancer is one of the most common cancers and generally affects women. It is a heterogeneous disease that presents different entities, different biological characteristics, and differentiated clinical behaviors. With this in mind, this literature review had as its main objective to analyze the path taken from the simple use of classical drugs to the application of mathematical models, which through the many ongoing studies, have been considered as one of the reliable strategies, explaining the reasons why chemotherapy is not always successful. Besides, the most commonly mentioned strategies are immunotherapy, which includes techniques and therapies such as the use of antibodies, cytokines, antitumor vaccines, oncolytic and genomic viruses, among others, and nanoparticles, including metallic, magnetic, polymeric, liposome, dendrimer, micelle, and others, as well as drug reuse, which is a process by which new therapeutic indications are found for existing and approved drugs. The most commonly used pharmacological categories are cardiac, antiparasitic, anthelmintic, antiviral, antibiotic, and others. For the efficient development of reused drugs, there must be a process of exchange of purposes, methods, and information already available, and for their better understanding, computational mathematical models are then used, of which the methods of blind search or screening, based on the target, knowledge, signature, pathway or network and the mechanism to which it is directed, stand out. To conclude it should be noted that these different strategies can be applied alone or in combination with each other always to improve breast cancer treatment.
format article
author Ana Costa
Nuno Vale
author_facet Ana Costa
Nuno Vale
author_sort Ana Costa
title Strategies for the treatment of breast cancer: from classical drugs to mathematical models
title_short Strategies for the treatment of breast cancer: from classical drugs to mathematical models
title_full Strategies for the treatment of breast cancer: from classical drugs to mathematical models
title_fullStr Strategies for the treatment of breast cancer: from classical drugs to mathematical models
title_full_unstemmed Strategies for the treatment of breast cancer: from classical drugs to mathematical models
title_sort strategies for the treatment of breast cancer: from classical drugs to mathematical models
publisher AIMS Press
publishDate 2021
url https://doaj.org/article/f221b853853047fda4c15f7bfe26d186
work_keys_str_mv AT anacosta strategiesforthetreatmentofbreastcancerfromclassicaldrugstomathematicalmodels
AT nunovale strategiesforthetreatmentofbreastcancerfromclassicaldrugstomathematicalmodels
_version_ 1718439643908669440